Enhancement of morphine actions in morphine-naive and morphine-tolerant mice by LY 235959, a competitive antagonist of the NMDA receptor

General Pharmacology

Volumn 28, Issue 1, 1997, Pages 61-64

  Bhargava, Hemendra N ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

analgesia; hypothermia; mice; morphine; NMDA receptor; tolerance

Indexed keywords

DECAHYDRO 6 PHOSPHONOMETHYL 3 ISOQUINOLINECARBOXYLIC ACID; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; DRUG POTENTIATION; HYPOTHERMIA; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MORPHINE ADDICTION; MORPHINE TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANALGESICS, OPIOID; ANIMALS; BINDING, COMPETITIVE; BODY TEMPERATURE; DRUG SYNERGISM; DRUG TOLERANCE; ISOQUINOLINES; MALE; MICE; MORPHINE; PAIN MEASUREMENT; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0031021794     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(96)00163-2     Document Type: Article

References (27)

1. G-Monomethyl-L-arginine coinjection attenuates the thermogenic and hypothalamic preoptic area in rats. Brain Res. 556, 157-160.
2. Angulo J. A., Williams A., Ledoux M., Watanabe Y. and McEwen B. S. (1995) Elevation of striatal and accumbal preproenkephalin, preprotachykinin and preprodynorphin mRNA abundance subsequent to N-methyl-D-aspartate receptor blockade with MK-801. Mol. Brain Res. 29, 15-22.
3. Bakshi R., Newman A. H. and Faden A. I. (1990) Dynorphin A-(1-17) induces alterations in free fatty acids, excitatory amino acids, and motor function through an opiate receptor-mediated mechanism. J. Neurosci. 10, 3793-3800.
4. Barjavel M. J. and Bhargava H. N. (1994a) Nitric oxide synthase activity in brain regions and spinal cord of mice and rats: kinetic analysis. Pharmacology 50, 168-174.
5. Barjavel M. J. and Bhargava H. N. (1994b) Effects of opioid receptor agonists on nitric oxide synthase activity in rat cerebral cortex homogenate. Neurosci. Lett. 181, 27-30.
6. Bhargava H. N. (1976) Effects of cannabinoids on naloxone-precipitated abstinence in morphine dependent mice. Psychopharmacology 49, 267-270.
7. Bhargava H. N. (1978) The effect of naltrexone on the development of physical dependence on morphine. Eur. J. Pharmac. 50, 193-202.
8. Bhargava H. N. (1994) Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome and self-administrative behavior. Pharmac. Rev. 46, 293-324.
9. Bhargava H. N. and Matwyshyn G. A. (1993) Dizocilpine (MK-801) blocks tolerance to the analgesic but not to the hyperthermic effect of morphine in the rat. Pharmacology 47, 344-350.
10. Bhargava H. N., Matwyshyn G. A. and Gudehithlu K. P. (1995) Effect of acute and chronic administration of dizocilpine on the pharmacological responses to U-50,488H and brain and spinal cord κ-opioid receptors in the rat. Pharmacology 51, 323-330.
11. Chavkin C., James I. F. and Goldstein, A. (1982) Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science 215, 413-415.
12. D'Amour F. E. and Smith D. L. (1941) A method for determining loss of pain sensation. J. Pharmac. Exp. Ther. 72, 74-79.
13. Gannon R. L. and Terrian D. M. (1992) Kappa opioid agonists inhibit transmitter release from guinea pig hippocampal mossy fiber synaptosomes. Neurochem. Res. 17, 741-747.
14. Garthwaite J., Garthwaite G., Palmer R. M. J. and Moncada, S. (1989) NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur. J. Pharmac. Mol. Pharmac. Sec. 172, 413-416.
15. Gudehithlu K. P. and Bhargava H. N. (1995) Effect of competitive and noncompetitive antagonism of NMDA receptor on preproenkephalin mRNA. Soc. Neuorsci. Abstr. 21, A724.
16. Johnson S. M. and Fleming W. W. (1989) Mechanisms of cellular adaptive sensitivity changes: applications to opioid tolerance and dependence. Pharmac. Rev. 41, 435-488.
17. Lutfy K., Hurlbut D. E. and Weber E. (1993) Blockade of morphine-induced analgesia and tolerance in mice by MK-801. Brain Res. 616, 83-88.
18. Marek P., Ben-Eliyahu S., Gold M. and Liebeskind J. C. (1991) Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat. Brain Res. 547, 77-81.
19. G-nitro arginine methyl ester exhibits antinociceptive activity in the mouse. Brit. J. Pharmac. 102, 198-202.
20. Moore P. K., Wallace P., Gaffen Z., Hart S. L. and Babbedge, R. C. (1993) Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: anti-nociceptive and cardiovascular effects. Brit. J. Pharmac. 110, 219-224.
21. Przewlocki R., Machelska H. and Prezewlocka B. (1993) Inhibition of nitric oxide synthase enhances morphine antinociception in the rat spinal cord. Life Sci. 53, 1-5.
22. Skilling S. R., Sun X., Kurtz H. J. and Larson A. A. (1992) Selective potentiation of NMDA-induced activity and release of excitatory aminoacids by dynorphin: possible roles in paralysis and neurotoxicity. Brain Res. 575, 272-278.
23. Thorat S. N. and Bhargava H. N. (1994) Evidence for a bidirectional cross-tolerance between morphine and delta-9-tetrahydrocannabinol in mice. Eur. J. Pharmac. 260, 5-13.
24. Tiseo P. J. and Inturrisi C. E. (1993) Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY 274614. J. Pharmac. Exp. Ther. 264, 1090-1096.
25. Tiseo P. J., Cheng J., Pasternak G. W. and Inturrisi C. E. (1994) Modulation of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY 274614: assessment of opioid receptor changes. J. Pharmac. Exp. Ther. 268, 195-201.
26. Trujillo K. A. and Akil H. (1991) Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251, 85-87.
27. Way E. L., Loh H. H. and Shen F. (1968) Simultaneous quantitative assessment of morphine tolerance and physical dependence. J. Pharmac. Exp. Ther. 167, 1-8.